Construction and high-level expression of a single-chain Fv antibody fragment specific for acidic isoferritin in Escherichia coli

被引:50
作者
Guo, JQ
You, SY
Li, L
Zhang, YZ
Huang, JN
Zhang, CY [1 ]
机构
[1] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China
[2] Childrens Hosp Wuhan, Clin Lab, Wuhan 430016, Peoples R China
[3] Med Res Inst Wuhan, Wuhan 430014, Peoples R China
关键词
scFv; acidic isoferritin; inclusion body; His-tag; on-column refolding;
D O I
10.1016/S0168-1656(03)00020-8
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A functional single-chain Fv antibody fragment (scFv) specific for acidic isoferritin (AIF) was produced at high level in Escherichia coli. The variable regions of heavy chain (V-H) and light chain (V-L) from the hybridoma 4c9 were connected with a flexible linker using an assembly polymerase chain reaction. The construct Of V-H-linker-V-L was inserted into a phagemid pCANTAB 5 E followed by selection with the Recombinant Phage Antibody System (RPAS). Anti-AIF scFv gene from the recombinant phagemid pCAN4c9 was subcloned into pET28a fused to N-terminal Histag sequence in frame and overexpressed in E. coli BL21(DE3). With an on-column refolding procedure based on Ni-chelating chromatography, the active anti-AIF scFv was recovered efficiently from inclusion bodies with a refolding yield of approximate 75% confirmed by spectrophotometer. The activity of refolded scFv was determined through sodium dodecyl sulfate-polyacrylamide gel electrophoresis, Western blotting and enzyme-linked immunosorbent assay. The results showed anti-AIF scFv retains the specific binding activity to AIF with an affinity constant of 7.29 x 10(-8) mol l(-1). The overall yield of anti-AIF scFv with bioactivity in E. coli flask culture was more than 60 mg l(-1). (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:177 / 189
页数:13
相关论文
共 39 条
[1]   Delivery of the α-emitting radioisotope bismuth-213 to solid tumors via single-chain Fv and diabody molecules [J].
Adams, GP ;
Shaller, CC ;
Chappell, LL ;
Wu, C ;
Horak, EM ;
Simmons, HH ;
Litwin, S ;
Marks, JD ;
Weiner, LM ;
Brechbiel, MW .
NUCLEAR MEDICINE AND BIOLOGY, 2000, 27 (04) :339-346
[2]  
ADAMS GP, 1993, CANCER RES, V53, P4026
[3]  
Adams GP, 1998, IN VIVO, V12, P11
[4]  
ALPERT E, 1975, CANCER RES, V35, P1505
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   A METHOD FOR INCREASING THE YIELD OF PROPERLY FOLDED RECOMBINANT FUSION PROTEINS - SINGLE-CHAIN IMMUNOTOXINS FROM RENATURATION OF BACTERIAL INCLUSION-BODIES [J].
BUCHNER, J ;
PASTAN, I ;
BRINKMANN, U .
ANALYTICAL BIOCHEMISTRY, 1992, 205 (02) :263-270
[7]   Production and in vitro refolding of a single-chain antibody specific for human plasma apolipoprotein A-I [J].
Cho, WK ;
Sohn, U ;
Kwak, JW .
JOURNAL OF BIOTECHNOLOGY, 2000, 77 (2-3) :169-178
[8]   Protein refolding for industrial processes [J].
Clark, ED .
CURRENT OPINION IN BIOTECHNOLOGY, 2001, 12 (02) :202-207
[9]  
Colcher D, 1998, Q J NUCL MED, V42, P225
[10]   INVIVO TUMOR TARGETING OF A RECOMBINANT SINGLE-CHAIN ANTIGEN-BINDING PROTEIN [J].
COLCHER, D ;
BIRD, R ;
ROSELLI, M ;
HARDMAN, KD ;
JOHNSON, S ;
POPE, S ;
DODD, SW ;
PANTOLIANO, MW ;
MILENIC, DE ;
SCHLOM, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (14) :1191-1197